353 related articles for article (PubMed ID: 19524472)
21. Adjuvant chemotherapy with doxorubicin and dacarbazine has no effect in recurrence-free survival of malignant phyllodes tumors of the breast.
Morales-Vásquez F; Gonzalez-Angulo AM; Broglio K; Lopez-Basave HN; Gallardo D; Hortobagyi GN; De La Garza JG
Breast J; 2007; 13(6):551-6. PubMed ID: 17983394
[TBL] [Abstract][Full Text] [Related]
22. Phyllodes tumours of the breast--a retrospective study from 1982-2000 of 50 cases in Portsmouth.
Sotheran W; Domjan J; Jeffrey M; Wise MH; Perry PM
Ann R Coll Surg Engl; 2005 Sep; 87(5):339-44. PubMed ID: 16176692
[TBL] [Abstract][Full Text] [Related]
23. Diagnosis and management of phyllodes tumour of the breast: experience of 33 cases at a specialist centre.
Stebbing JF; Nash AG
Ann R Coll Surg Engl; 1995 May; 77(3):181-4. PubMed ID: 7598414
[TBL] [Abstract][Full Text] [Related]
24. Surgical treatment of borderline and malignant phyllodes tumors: the effect of the extent of resection and tumor characteristics on patient outcome.
Onkendi EO; Jimenez RE; Spears GM; Harmsen WS; Ballman KV; Hieken TJ
Ann Surg Oncol; 2014 Oct; 21(10):3304-9. PubMed ID: 25034817
[TBL] [Abstract][Full Text] [Related]
25. [Phyllodes tumor of the breast: diagnostic and therapeutic problems].
Gangi S; Costanzo MP; Prosperini U; Lauria M; Furci M; Strano S; Basile F
Ann Ital Chir; 1996; 67(2):219-23. PubMed ID: 8929037
[TBL] [Abstract][Full Text] [Related]
26. Retrospective analysis of 25 women with malignant cystosarcoma phyllodes--treatment results.
Soumarová R; Seneklová Z; Horová H; Vojkovská H; Horová I; Budíková M; Růzicková J; Jezková B
Arch Gynecol Obstet; 2004 May; 269(4):278-81. PubMed ID: 15205980
[TBL] [Abstract][Full Text] [Related]
27. Immediate breast reconstruction for phyllodes tumors.
Singh G; Sharma RK
Breast; 2008 Jun; 17(3):296-301. PubMed ID: 18155550
[TBL] [Abstract][Full Text] [Related]
28. Ductal carcinoma in situ of the breast with close or focally involved margins following breast-conserving surgery: treatment with reexcision or radiotherapy with increased dosage.
Monteau A; Sigal-Zafrani B; Kirova YM; Fourchotte V; Bollet MA; Vincent-Salomon A; Asselain B; Salmon RJ; Fourquet A
Int J Radiat Oncol Biol Phys; 2009 Nov; 75(4):1021-8. PubMed ID: 19386441
[TBL] [Abstract][Full Text] [Related]
29. Utilization of radiotherapy for malignant phyllodes tumors: analysis of the National Cancer Data Base, 1998-2009.
Gnerlich JL; Williams RT; Yao K; Jaskowiak N; Kulkarni SA
Ann Surg Oncol; 2014 Apr; 21(4):1222-30. PubMed ID: 24306659
[TBL] [Abstract][Full Text] [Related]
30. Primary sarcoma of the breast.
Pandey M; Mathew A; Abraham EK; Rajan B
J Surg Oncol; 2004 Sep; 87(3):121-5. PubMed ID: 15334638
[TBL] [Abstract][Full Text] [Related]
31. Phyllodes tumor of breast.
Shabbir J; O'Sullivan JB; Mahmood S; Byrnes G
J Coll Physicians Surg Pak; 2003 Mar; 13(3):170-1. PubMed ID: 12689541
[TBL] [Abstract][Full Text] [Related]
32. Clinicopathologic risk factors for the local recurrence of phyllodes tumors of the breast.
Jang JH; Choi MY; Lee SK; Kim S; Kim J; Lee J; Jung SP; Choe JH; Kim JH; Kim JS; Cho EY; Lee JE; Nam SJ; Yang JH
Ann Surg Oncol; 2012 Aug; 19(8):2612-7. PubMed ID: 22476816
[TBL] [Abstract][Full Text] [Related]
33. [Phyllodes tumor of the breast (cystosarcoma phyllodes) (apropos 3 cases)].
Genoni E; Bonzi F; Boccazzi G; Maffioletti G; Re Ferrè M; Bernieri A; Ciprandi G
Chir Ital; 1990; 42(1-2):59-68. PubMed ID: 1963818
[TBL] [Abstract][Full Text] [Related]
34. [Phyllodes tumors of the breast. Forty one cases].
Matar N; Soumani A; Noun M; Chraibi T; Himmi A; el Mansouri A; Aderdour M; Bekkay M
J Gynecol Obstet Biol Reprod (Paris); 1997; 26(1):32-6. PubMed ID: 9091541
[TBL] [Abstract][Full Text] [Related]
35. Breast-conserving treatment in the elderly: long-term results of adjuvant hypofractionated and normofractionated radiotherapy.
Kirova YM; Campana F; Savignoni A; Laki F; Muresan M; Dendale R; Bollet MA; Salmon RJ; Fourquet A;
Int J Radiat Oncol Biol Phys; 2009 Sep; 75(1):76-81. PubMed ID: 19168297
[TBL] [Abstract][Full Text] [Related]
36. Correlation of p53 and MIB-1 expression with both the systemic recurrence and survival in cases of phyllodes tumors of the breast.
Yonemori K; Hasegawa T; Shimizu C; Shibata T; Matsumoto K; Kouno T; Ando M; Katsumata N; Fujiwara Y
Pathol Res Pract; 2006; 202(10):705-12. PubMed ID: 16889904
[TBL] [Abstract][Full Text] [Related]
37. Cystosarcoma phyllodes and its surgical management.
Buchanan EB
Am Surg; 1995 Apr; 61(4):350-5. PubMed ID: 7893104
[TBL] [Abstract][Full Text] [Related]
38. Cystosarcoma phylloides of the breast: a new therapeutic proposal.
Contarini O; Urdaneta LF; Hagan W; Stephenson SE
Am Surg; 1982 Apr; 48(4):157-66. PubMed ID: 6282155
[TBL] [Abstract][Full Text] [Related]
39. Malignant transformation of breast fibroadenoma to malignant phyllodes tumor: long-term outcome of 36 malignant phyllodes tumors.
Abe M; Miyata S; Nishimura S; Iijima K; Makita M; Akiyama F; Iwase T
Breast Cancer; 2011 Oct; 18(4):268-72. PubMed ID: 22121516
[TBL] [Abstract][Full Text] [Related]
40. Malignant phyllodes tumor of the breast: treatment and prognosis.
Mituś J; Reinfuss M; Mituś JW; Jakubowicz J; Blecharz P; Wysocki WM; Skotnicki P
Breast J; 2014; 20(6):639-44. PubMed ID: 25227987
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
